Microbial Biofilms and Host Immune Response

A special issue of Microbiology Research (ISSN 2036-7481).

Deadline for manuscript submissions: closed (30 July 2023) | Viewed by 3736

Special Issue Editor


E-Mail Website
Guest Editor
Department of Endodontics, University of the Pacific, Arthur A. Dugoni School of Dentistry 155 Fifth Street, San Francisco, CA 94103, USA
Interests: antimicrobial therapeutics; biofilms; multifunctional materials; infection-immunity interrelationships
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The human body is home to a large number of microorganisms belonging to various kingdoms. Under normal circumstances, the host surmounts an immune response that keeps pathogens at bay. However, when dysbiosis strikes under conditions unfavorable to the host, the pathogens overwhelm the otherwise remarkably effective host immune system to cause disease. As such, biofilm entities are tolerant to most antimicrobials, and antimicrobial resistance is a growing concern. Novel anti-virulent strategies are now emerging where microbes do not have a sufficient incentive to develop resistance mechanisms. On the other side of the spectrum, rapid killing approaches such as antimicrobial peptides are also being developed. An innovative approach is reprogramming host immune cells to surmount a profound attack to kill pathogens. Indeed, pathogens are no less smart either. They rapidly devise escape mechanisms such as internalization into host cells to thwart efforts by the host immune mechanisms. To deliver efficient therapeutics that will stand the test of time, understanding and acknowledging the intricate balance between infection and immunity are critical. In line with this philosophy, this Special Issue invites reviews and original research submissions from scientists in the areas of microbial (bacterial and fungal) biofilms, impact of biofilms on host immune and non-immune cells, model systems to study microbe–host interactions, novel antimicrobial therapeutics, immunomodulatory approaches and multi-functional therapeutics.

Dr. Prasanna Neelakantan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microbiology Research is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biofilm
  • infection
  • macrophage
  • keratinocyte
  • host immune response
  • antimicrobial
  • immunomodulation
  • anti-virulence

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 410 KiB  
Review
Stenotrophomonas maltophilia and Its Ability to Form Biofilms
by Gina García, Jorge A. Girón, Jorge A. Yañez and María L. Cedillo
Microbiol. Res. 2023, 14(1), 1-20; https://doi.org/10.3390/microbiolres14010001 - 23 Dec 2022
Cited by 10 | Viewed by 3396
Abstract
In the last ten years, Stenotrophomonas maltophilia has gained increasing interest as an important agent of infection, which is why it has come to be recognized as a serious cause of nosocomial infections related to bloodstream infections, pneumonia, and cancer, mainly in patients [...] Read more.
In the last ten years, Stenotrophomonas maltophilia has gained increasing interest as an important agent of infection, which is why it has come to be recognized as a serious cause of nosocomial infections related to bloodstream infections, pneumonia, and cancer, mainly in patients with intensive care, and is associated with high mortality rates in immunocompromised patients, with prolonged hospital stays and extensive use of antimicrobials. The importance of this microorganism lies in its low pathogenicity, high multiresistance to various antibiotics, and frequent and persistent isolation in predisposed patients. In addition, few studies have evaluated its epidemiology and clinical relevance. The pathogenesis of biofilms lies mainly in the fact that they can generate persistent chronic infections that are difficult to eradicate. To this extent, it is important to make the characteristics of the biofilm formation behavior of Stenotrophomonas maltophilia known and generate more knowledge about its colonization or infection in humans through this review, which discusses more recent information. Full article
(This article belongs to the Special Issue Microbial Biofilms and Host Immune Response)
Back to TopTop